CVE-2026-3401: Session Expiration in SourceCodester Web-based Pharmacy Product Management System
A weakness has been identified in SourceCodester Web-based Pharmacy Product Management System 1.0. This affects an unknown part. This manipulation causes session expiration. Remote exploitation of the attack is possible. The complexity of an attack is rather high. It is indicated that the exploitability is difficult. The exploit has been made available to the public and could be used for attacks.
AI Analysis
Technical Summary
CVE-2026-3401 identifies a session expiration vulnerability in SourceCodester's Web-based Pharmacy Product Management System version 1.0. The weakness allows an attacker to manipulate session expiration remotely, potentially causing legitimate user sessions to terminate unexpectedly. The exact component or mechanism affected is unspecified, but the vulnerability impacts session management functionality. The attack vector is network-based (AV:N), requiring low privileges (PR:L) but no user interaction (UI:N). The attack complexity is high (AC:H), indicating that exploitation demands advanced skills or specific conditions. The vulnerability does not affect confidentiality, integrity, or availability significantly (VC:N, VI:L, VA:N), resulting in a low CVSS 4.0 score of 2.3. No known exploits are currently active in the wild, though exploit code has been publicly disclosed. The vulnerability could disrupt user workflows by forcing session terminations, potentially leading to denial of service for legitimate users or administrative inconvenience. The lack of patches or detailed technical information suggests that mitigation relies on configuration adjustments or future vendor updates. This vulnerability highlights the importance of robust session management in web-based healthcare management systems, where session reliability is critical for operational continuity and data security.
Potential Impact
The primary impact of CVE-2026-3401 is the potential disruption of user sessions within the affected pharmacy product management system. This can lead to denial of service for legitimate users, interrupting critical workflows in pharmacy management and possibly delaying medication dispensing or inventory management. Although the vulnerability does not directly compromise confidentiality or integrity, session interruptions can degrade user experience and operational efficiency. In healthcare environments, such disruptions may indirectly affect patient care quality or compliance with regulatory requirements. The high complexity of exploitation and requirement for some privileges limit the likelihood of widespread attacks, reducing the overall risk. However, the public availability of exploit code increases the potential for targeted attacks by skilled adversaries. Organizations relying on this system should be aware of possible session management issues that could affect system availability and user productivity.
Mitigation Recommendations
To mitigate CVE-2026-3401, organizations should implement the following specific measures: 1) Monitor for official patches or updates from SourceCodester and apply them promptly once available. 2) Review and strengthen session management configurations, including session timeout values, secure cookie attributes (HttpOnly, Secure), and session token regeneration policies. 3) Implement network-level controls such as web application firewalls (WAFs) to detect and block suspicious session manipulation attempts. 4) Enforce strict access controls and privilege management to limit the ability of low-privilege users to exploit the vulnerability. 5) Conduct regular security assessments and penetration testing focused on session management to identify and remediate weaknesses proactively. 6) Educate system administrators and users about the importance of secure session handling and recognizing potential session-related anomalies. These targeted actions go beyond generic advice by focusing on session-specific controls and proactive monitoring tailored to the affected product's context.
Affected Countries
United States, India, Brazil, Germany, United Kingdom, Canada, Australia, France, South Africa, Philippines
CVE-2026-3401: Session Expiration in SourceCodester Web-based Pharmacy Product Management System
Description
A weakness has been identified in SourceCodester Web-based Pharmacy Product Management System 1.0. This affects an unknown part. This manipulation causes session expiration. Remote exploitation of the attack is possible. The complexity of an attack is rather high. It is indicated that the exploitability is difficult. The exploit has been made available to the public and could be used for attacks.
AI-Powered Analysis
Machine-generated threat intelligence
Technical Analysis
CVE-2026-3401 identifies a session expiration vulnerability in SourceCodester's Web-based Pharmacy Product Management System version 1.0. The weakness allows an attacker to manipulate session expiration remotely, potentially causing legitimate user sessions to terminate unexpectedly. The exact component or mechanism affected is unspecified, but the vulnerability impacts session management functionality. The attack vector is network-based (AV:N), requiring low privileges (PR:L) but no user interaction (UI:N). The attack complexity is high (AC:H), indicating that exploitation demands advanced skills or specific conditions. The vulnerability does not affect confidentiality, integrity, or availability significantly (VC:N, VI:L, VA:N), resulting in a low CVSS 4.0 score of 2.3. No known exploits are currently active in the wild, though exploit code has been publicly disclosed. The vulnerability could disrupt user workflows by forcing session terminations, potentially leading to denial of service for legitimate users or administrative inconvenience. The lack of patches or detailed technical information suggests that mitigation relies on configuration adjustments or future vendor updates. This vulnerability highlights the importance of robust session management in web-based healthcare management systems, where session reliability is critical for operational continuity and data security.
Potential Impact
The primary impact of CVE-2026-3401 is the potential disruption of user sessions within the affected pharmacy product management system. This can lead to denial of service for legitimate users, interrupting critical workflows in pharmacy management and possibly delaying medication dispensing or inventory management. Although the vulnerability does not directly compromise confidentiality or integrity, session interruptions can degrade user experience and operational efficiency. In healthcare environments, such disruptions may indirectly affect patient care quality or compliance with regulatory requirements. The high complexity of exploitation and requirement for some privileges limit the likelihood of widespread attacks, reducing the overall risk. However, the public availability of exploit code increases the potential for targeted attacks by skilled adversaries. Organizations relying on this system should be aware of possible session management issues that could affect system availability and user productivity.
Mitigation Recommendations
To mitigate CVE-2026-3401, organizations should implement the following specific measures: 1) Monitor for official patches or updates from SourceCodester and apply them promptly once available. 2) Review and strengthen session management configurations, including session timeout values, secure cookie attributes (HttpOnly, Secure), and session token regeneration policies. 3) Implement network-level controls such as web application firewalls (WAFs) to detect and block suspicious session manipulation attempts. 4) Enforce strict access controls and privilege management to limit the ability of low-privilege users to exploit the vulnerability. 5) Conduct regular security assessments and penetration testing focused on session management to identify and remediate weaknesses proactively. 6) Educate system administrators and users about the importance of secure session handling and recognizing potential session-related anomalies. These targeted actions go beyond generic advice by focusing on session-specific controls and proactive monitoring tailored to the affected product's context.
Technical Details
- Data Version
- 5.2
- Assigner Short Name
- VulDB
- Date Reserved
- 2026-03-01T06:43:59.046Z
- Cvss Version
- 4.0
- State
- PUBLISHED
Threat ID: 69a4e02a32ffcdb8a2fae9b6
Added to database: 3/2/2026, 12:56:10 AM
Last enriched: 3/9/2026, 1:25:32 AM
Last updated: 4/15/2026, 1:56:57 PM
Views: 155
Community Reviews
0 reviewsCrowdsource mitigation strategies, share intel context, and vote on the most helpful responses. Sign in to add your voice and help keep defenders ahead.
Want to contribute mitigation steps or threat intel context? Sign in or create an account to join the community discussion.
Actions
Updates to AI analysis require Pro Console access. Upgrade inside Console → Billing.
Need more coverage?
Upgrade to Pro Console for AI refresh and higher limits.
For incident response and remediation, OffSeq services can help resolve threats faster.
Latest Threats
Check if your credentials are on the dark web
Instant breach scanning across billions of leaked records. Free tier available.